CANbridge Pharmaceuticals Inc. (HKG:1228)

CANbridge Pharmaceuticals Revenue

In the year 2025, CANbridge Pharmaceuticals had annual revenue of 49.98M CNY, down -41.27%. CANbridge Pharmaceuticals had revenue of 27.74M in the half year ending December 31, 2025, a decrease of -53.64%.

• Revenue: 49.98M CNY
• Revenue Growth: -41.27%
• P/S Ratio: 27.83
• Revenue / Employee: 1.22M CNY
• Employees: 41
• Market Cap: 1.55B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.98M	-35.12M	-41.27%
Dec 31, 2024	85.10M	-17.77M	-17.27%
Dec 31, 2023	102.87M	23.90M	30.26%
Dec 31, 2022	78.97M	47.81M	153.43%
Dec 31, 2021	31.16M	19.13M	158.98%